Australian medicinal cannabis firm Cann has moved quickly to maximise the benefits of its CBD Gelpell capsule technology by entering into a collaboration deal with healthcare technology firm Emyria
Submit your access request to explore how it can streamlines access to critical cannabis insights
"*" indicates required fields
Notifications